Infertility, fertility drugs, and invasive ovarian cancer: A case- control study

Fertility and Sterility

Volumn 67, Issue 6, 1997, Pages 1005-1012

  Mosgaard, Berit Jul ^a   Schou, Geert ^a,b   Lidegaard, Øjvind ^a   Andersen, Anders Nyboe ^a   Kjaer, Susanne Krüger ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

Case control study; Epidemiology; Fertility drugs; Infertility; Parity

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; FERTILITY PROMOTING AGENT; HUMAN MENOPAUSAL GONADOTROPIN;

ADULT; ARTICLE; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; DENMARK; FEMALE; FEMALE INFERTILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIPARA; NULLIPARA; ORAL DRUG ADMINISTRATION; OVARY CANCER; PARITY; PRIORITY JOURNAL;

EID: 0343145727     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)81431-8     Document Type: Article

References (25)

1. McGowan L, Parent L, Lednar W, Norris HJ. The woman at risk for developing ovarian cancer. Gynecol Oncol 1979; 7: 325-44.
2. Cramer DW, Hutchison GB, Welch WR, Scully RE, Ryan KJ. Determinants of ovarian cancer risk. I. Reproductive experiences and family history. J Natl Cancer Inst 1983; 71:711-6.
3. Hartge P, Schiffman MH, Hoover R, McGowan L, Lesher L, Norris HJ. A case-control study of epithelial ovarian cancer. Am J Obstet Gynecol 1989; 161:10-6.
4. Risch HA, Marrett LD, Howe GR. Parity, contraception, infertility, and the risk of epithelial ovarian cancer. Am J Epidemiol 1994; 140:585-97.
5. Adami HO, Hsieh CC, Lambe M, Trichopoulos D, Leon D, Persson I, et al. Parity, age at first childbirth, and risk of ovarian cancer. Lancet 1994;344:1250-4.
6. Whittemore AS, Harris R, Itnyre J. Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. J Epidemiol 1992; 136:1184-203.
7. Brinton LA, Melton LJ 3d, Malkasian GD Jr, Bond A, Hoover R. Cancer risk after evaluation for infertility. Am J Epidemiol 1989; 129:712-22.
8. Ron E, Lunenfeld B, Menczer J, Blumstein T, Katz L, Oelsner G, et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1987; 125:780-90.
9. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994;331:771-6.
10. Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 1995; 346:995-1000.
11. Franceschi S, La Vecchia C, Negri E, Guarneri S, Montella M, Conti E, et al. Fertility drugs and risk of epithelial ovarian cancer in Italy. Hum Reprod 1994;9:1673-5.
12. Shushan A, Paltiel O, Iscovich J, Elchalal U, Peretz T, Schenker JG. Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril 1996;65:13-8.
13. Mosgaard B, Lidegaard O, Andersen AN. Use of fertility drugs in Denmark 1973-1993: an analysis based on sale statistics. Acta Obstet Gynecol Scand 1995; 95:614-8.
14. Casagrande JT, Louie EW, Pike MC, Roy S, Ross RK, Henderson BE. "Incessant ovulation" and ovarian cancer. Lancet 1979;2:170-3.
15. Hartge P, Whittemore AS, Itnyre J, McGowan L, Cramer D. The Collaborative Ovarian Cancer Group. Rates and risks of ovarian cancer in subgroups of white women in the United States. Obstet Gynecol 1994;84:760-4.
16. Negri E, Franceschi S, Tzonou A, Booth M, La Vecchia C, Parazzini F, et al. Pooled analysis of 3 European case-control studies: I. Reproductive factors and risk of epithelial ovarian cancer. Int J Cancer 1991;49:50-6.
17. Booth M, Beral V, Smith P. Risk factors for ovarian cancer: a case-control study. Br J Cancer 1989;60:592-8.
18. Nasca PC, Greenwald P, Chorost S, Richart R, Caputo T. An epidemiologic case-control study of ovarian cancer and reproductive factors. Am J Epidemiol 1984; 119:705-13.
19. Hildreth NG, Kelsey JL, LiVolsi VA, Fischer DB, Holford TR, Mostow ED, et al. An epidemiologic study of epithelial carcinoma of the ovary. Am J Epidemiol 1981; 114:398-405.
20. Whittemore AS, Wu ML, Paffenbarger RS Jr, Sarles DL, Kampert JB, Grosser S, et al. Epithelial ovarian cancer and the ability to conceive. Cancer Res 1989;49:4047-52.
21. Piver MS, Baker TR, Jishi MF, Sandecki AM, Tsukada Y, Natarajan N, et al. Familial ovarian cancer: a report of 658 families from the Gilda Radner Familial Ovarian Cancer Registry 1981-1991. Cancer 1993;71:Suppl:582-8.
22. Adami HO, Persson I, Hoover R, Schairer C, Bergkvist L. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 1989;44:833-9.
23. Rodriguez C, Calle EE, Coates RJ, Miracle-McMahill HL, Thun MJ, Heath CW Jr. Estrogen replacement therapy and fatal ovarian cancer. Am J Epidemiol 1995; 141:828-35.
24. Cohen J, Forman R, Harlap S, Johannisson E, Lunenfeld B, de Mouzon J, et al. IFFS expert group report on the Whitte-more study related to the risk of ovarian cancer associated with the use of infertility agents. Hum Reprod 1993; 8: 996-9.
25. Shapiro S. Risk of ovarian cancer after treatment for infertility. N Engl J Med 1995;332:1301.